Invention Grant
- Patent Title: Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
-
Application No.: US16872114Application Date: 2020-05-11
-
Publication No.: US11078171B2Publication Date: 2021-08-03
- Inventor: Paul S. Shapiro , Alexander D. Mackerell, Jr. , Jeffrey D. Hasday , Steven Fletcher
- Applicant: University of Maryland, Baltimore
- Applicant Address: US MD Baltimore
- Assignee: University of Maryland, Baltimore
- Current Assignee: University of Maryland, Baltimore
- Current Assignee Address: US MD Baltimore
- Main IPC: C07D295/03
- IPC: C07D295/03
Abstract:
Compounds that inhibit p38α MAPK protein, and methods of using the same, are provided for treating or preventing diseases such as cancer or inflammatory diseases.
Public/Granted literature
- US20200331874A1 NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS Public/Granted day:2020-10-22
Information query
